Search Results
Baxter Releases 2017 Corporate Responsibility Report and Reinforces its Commitment to Enriching Communities Around the World
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today released its 2017 Corporate Responsibility Report, highlighting its efforts to create lasting social, economic and environmental value in the communities the company serves around the world.
Baxter Unveiled Updates to SHARESOURCE Remote Patient Management Platform for Home Dialysis Patients at ERA-EDTA 2018
Baxter International Inc. (NYSE: BAX), a global innovator in renal care, announced the availability of two program updates for its SHARESOURCE remote patient management platform to support greater accessibility and efficiencies in remotely viewing patient data.
Baxter Supported Nine New Abstract Presentations at the 55th ERA-EDTA Congress that Further Demonstrate Value of HDX Therapy Enabled by THERANOVA
Baxter International Inc. (NYSE: BAX), a global innovator in renal care, announced new data reinforcing that expanded hemodialysis (HDx) enabled by the THERANOVA dialyzer clears large middle molecules at a higher rate when compared to standard hemodialysis (HD), and equivalent or higher removal rates compared to high-volume hemodiafiltration (HDF). Two studies presented also found that albumin levels remained stable during HDx treatment.
Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference
Baxter International Inc. (NYSE: BAX), today at its investor conference, outlined the company’s strategies to drive sustained growth, deliver attractive shareholder value and advance patient care around the world. Baxter defined its top-quartile goals around four key areas: patient safety and quality; growth through innovation; best place to work; and industry-leading performance; and its leadership team highlighted strategic growth opportunities across its six global businesses.
Baxter to Present at the Goldman Sachs Healthcare Conference
Baxter International Inc. (NYSE: BAX) will present at the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, 2018 in Rancho Palos Verdes, CA. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present at 3:20 p.m. Pacific Daylight Time. The live webcast of Baxter’s presentation, can be accessed at www.baxter.com and will be available for replay through August 12, 2018.
Finding Strength Through Home Parenteral Nutrition (HPN) Therapy
Jana can often be found with her husband Chase walking their dogs Linus and Jovie in her hometown of Beaumont, Texas. She is a charismatic young woman who leads a very active and social lifestyle, whether it’s getting together with friends or hiking in New Mexico with her bright green backpack. But what many don’t realize is that the backpack Jana’s wearing is an extension of her body, as it carries the nutrients and calories that she will consume for the day.
Baxter to Host 2018 Investor Conference
Baxter International Inc. (NYSE: BAX) will host an investor conference on Monday, May 21, 2018 in New York City at the Pierre Hotel. The investor conference will feature an innovation hall displaying product and therapy advancements from Baxter’s pipeline beginning at 7:00 a.m. EDT, and will again be available following the conclusion of the formal presentations at 12:30 p.m. EDT. Presentations by members of the Baxter management team will commence at 8:00 a.m. EDT.
Baxter Announces U.S. FDA Clearance of New Spectrum IQ Infusion System
Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication delivery, today announced the U.S. Food and Drug Administration (FDA) clearance of the Spectrum IQ Infusion System with Dose IQ Safety Software.
Baxter Declares Dividend and Announces Quarterly Dividend Increase
Baxter International Inc. (NYSE:BAX) today announced an approximately 19% increase in the company’s quarterly dividend rate. This rate increase was made in connection with the declaration of a quarterly cash dividend of $0.19 per share of common stock (up from $0.16 per share), payable on July 2, 2018, to stockholders of record as of June 1, 2018. The indicated annual dividend rate is now $0.76 per share of common stock.
Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease
Baxter International Inc. (NYSE:BAX), a global innovator in renal (kidney) care, and the International Society of Nephrology (ISN) announced a partnership to advance chronic kidney disease (CKD) awareness and help improve access to therapy, particularly in low- and middle-income countries (LMIC) – commonly referenced as emerging markets – where the disease prevalence is growing the fastest.